Kenneth Hoberman's Net Worth
$12.2 Million
Who is Kenneth Hoberman?
Kenneth Hoberman has an estimated net worth of $12.2 Million. This is based on reported shares across multiple companies, which include Nuvectis Pharma, Inc., TG THERAPEUTICS, INC., and STEMLINE THERAPEUTICS INC.
SEC CIK
Kenneth Hoberman's CIK is 0001573722
Past Insider Trading and Trends
2016 was Kenneth Hoberman's most active year for acquiring shares with 5 total transactions. Kenneth Hoberman's most active month to acquire stocks was the month of May. 2019 was Kenneth Hoberman's most active year for disposing of shares, totalling 13 transactions. Kenneth Hoberman's most active month to dispose stocks was the month of February. 2015 saw Kenneth Hoberman paying a total of $110,859.45 for 125,352 shares, this is the most they've acquired in one year. In 2019 Kenneth Hoberman cashed out on 172,425 shares for a total of $2,168,902.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvectis Pharma, Inc. (NVCT) Snapshot price: $6.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.02% | 30K |
—
|
—
| 103.14K |
Jun 13
| |||
Form 4
| +32.64% | 18K |
—
|
—
| 73.14K |
Jun 16
| |||
Form 4
| +12.21% | 6K |
$17.40 | $104,400.00 | 55.14K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TG THERAPEUTICS, INC. (TGTX) Snapshot price: $22.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.17% | 22.25K |
—
|
—
| 264.94K |
Jun 19
| |||
Form 4
| +8.98% | 20K |
—
|
—
| 242.69K |
Sep 28
| |||
Form 4
| +24.44% | 43.73K |
—
|
—
| 222.69K |
Jul 20
| |||
Form 4
| +12.58% | 20K |
—
|
—
| 178.95K |
Jun 18
| |||
Form 4
| +10.42% | 15K |
—
|
—
| 158.95K |
Jun 22
| |||
Form 4
| +23.14% | 27.05K |
—
|
—
| 143.95K |
Sep 17
| |||
Form 4
| +14.72% | 15K |
—
|
—
| 116.91K |
Jun 26
| |||
Form 4
| +17.26% | 15K |
—
|
—
| 101.91K |
Jun 16
| |||
Form 4
| +16.74% | 12.46K |
—
|
—
| 86.91K |
Jul 6
| |||
Form 4
| +6.69% | 4.67K |
—
|
—
| 74.45K |
Jun 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STEMLINE THERAPEUTICS INC No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -774.35K |
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -3.28% | -26.19K |
$4.97 | -$130,210.60 | 771.76K |
Mar 9 - Mar 10
| |||
Form 4
| -1.43% | -11.55K |
$6.42 | -$74,131.74 | 797.96K |
Feb 25
| |||
Form 4
| +34.67% | 208.42K |
—
|
—
| 809.5K |
Feb 10
| |||
Form 4
| -3.55% | -22.14K |
$7.02 | -$155,415.78 | 601.09K |
Jan 22
| |||
Form 4
| -2.08% | -13.23K |
$10.37 | -$137,174.36 | 623.22K |
Jan 8
| |||
Form 4
| -6.78% | -46.31K |
$10.84 | -$501,958.77 | 636.45K |
Dec 23 - Dec 27
| |||
Form 4
| -6.46% | -47.12K |
$15.07 | -$710,095.59 | 682.76K |
Jun 24 - Jun 26
| |||
Form 4
| -3.42% | -25.82K |
$14.27 | -$368,408.59 | 729.88K |
May 14
| |||
Form 4
| -3.34% | -26.08K |
$11.11 | -$289,702.35 | 755.7K |
Mar 11 - Mar 12
| |||
Form 4
| -0.38% | -3.00K |
$11.36 | -$34,023.20 | 781.78K |
Mar 7
| |||
Form 4
| -1.33% | -10.56K |
$12.05 | -$127,211.85 | 784.77K |
Feb 25
| |||
Form 4
| +22.99% | 148.68K |
—
|
—
| 795.33K |
Feb 6
| |||
Form 4
| -2.05% | -13.55K |
$10.15 | -$137,502.05 | 646.65K |
Jan 8
| |||
Form 4
| -3.83% | -26.30K |
$11.85 | -$311,607.60 | 659.74K |
Nov 26
| |||
Form 4
| +66.90% | 275K |
—
|
—
| 686.03K |
Sep 12
| |||
Form 4
| -6.82% | -29.99K |
$17.14 | -$514,085.04 | 409.59K |
Mar 12 - Mar 13
| |||
Form 4
| +18.07% | 67.28K |
$16.55 | -$50,096.85 | 439.58K |
Mar 7 - Mar 8
| |||
Form 4
| -2.88% | -11.03K |
$17.43 | -$192,163.76 | 371.92K |
Feb 26 - Feb 27
| |||
Form 4
| -0.48% | -1.85K |
$15.67 | -$29,005.17 | 382.94K |
Feb 15
| |||
Form 4
| -3.52% | -14.04K |
$13.93 | -$195,577.20 | 384.79K |
Jan 8
| |||
Form 4
| -2.92% | -11.98K |
$14.18 | -$169,941.74 | 398.83K |
Dec 15 - Dec 18
| |||
Form 4
| +46.11% | 129.13K |
$8.16 | -$19,110.72 | 409.14K |
Mar 7 - Mar 9
| |||
Form 4
| -2.79% | -8.03K |
$6.99 | -$56,109.27 | 279.65K |
Feb 27 - Feb 28
| |||
Form 4
| -0.52% | -1.51K |
$6.42 | -$9,681.36 | 287.68K |
Feb 16
| |||
Form 4
| -3.05% | -9.11K |
$13.82 | -$125,900.20 | 289.19K |
Jan 10
| |||
Form 4
| -0.80% | -2.41K |
$5.34 | -$12,880.08 | 297.39K |
Mar 8
| |||
Form 4
| +41.69% | 87.98K |
—
|
—
| 299.04K |
Feb 24
| |||
Form 4
| -0.71% | -1.50K |
$4.54 | -$6,823.62 | 211.06K |
Feb 17
| |||
Form 4
| +239.76% | 150K |
—
|
—
| 212.56K |
Jan 7
| |||
Form 4
| -49.13% | -60.00K |
—
|
—
| 62.12K |
Dec 16 - Dec 31
| |||
Form 4
| +8.72% | 9.8K |
$10.26 | -$173,494.56 | 122.12K |
Mar 19
| |||
Form 4
| +27.72% | 24.38K |
—
|
—
| 112.32K |
Mar 6
| |||
Form 4
| -1.78% | -1.59K |
$14.02 | -$22,333.86 | 87.94K |
Feb 18
| |||
Form 4
| +2.28% | 2K |
$10.99 | $21,975.40 | 89.53K |
Sep 2
| |||
Form 4
| -14.84% | -15.25K |
$13.32 | -$203,130.00 | 87.53K |
May 21
| |||
Form 4
| +17.07% | 14.98K |
—
|
—
| 102.78K |
Feb 14
| |||
Form 4
| +355.21% | 68.51K |
$10.92 | -$795,254.71 | 87.8K |
Nov 22 - Nov 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||